PROCESS FOR ENRICHING IGA
    42.
    发明申请
    PROCESS FOR ENRICHING IGA 有权
    加强IGA的过程

    公开(公告)号:US20150005476A1

    公开(公告)日:2015-01-01

    申请号:US14377535

    申请日:2013-03-08

    申请人: CSL BEHRING AG

    IPC分类号: C07K16/06 C07K16/18

    摘要: The invention relates to a process for enriching IgA (and IgM) from IgA-comprising material. In particular, it relates to a sequential elution process of an anion exchanger that leads to an advantageous enrichment and separation of monomeric and dimeric IgA.

    摘要翻译: 本发明涉及从含IgA的材料中富集IgA(和IgM)的方法。 特别地,其涉及阴离子交换剂的顺序洗脱过程,其导致单体和二聚体IgA的有利的富集和分离。

    CD89 ACTIVATION IN THERAPY
    43.
    发明申请
    CD89 ACTIVATION IN THERAPY 有权
    CD89激活治疗

    公开(公告)号:US20130302345A1

    公开(公告)日:2013-11-14

    申请号:US13991811

    申请日:2011-12-14

    IPC分类号: A61K39/395

    摘要: The invention relates to the use of CD89 activating molecules, in particular Fc alpha comprising molecules, and more particularly, IgA, for inducing apoptosis in neutrophils. Anti-CD89 antibodies can alternatively be used. The CD89 activation is beneficial in the treatment of various disorders associated with increases in neutrophils, such as autoimmune disorders, inflammatory disorders, NETosis, or cystic fibrosis.

    摘要翻译: 本发明涉及CD89活化分子,特别是包含分子的Fcα,更具体地,IgA用于诱导嗜中性粒细胞凋亡的用途。 也可以使用抗CD89抗体。 CD89激活有益于治疗与嗜中性粒细胞增多有关的各种疾病,例如自身免疫性疾病,炎性疾病,NETosis或囊性纤维化。

    Immunoglobulin fractions
    44.
    发明授权
    Immunoglobulin fractions 有权
    免疫球蛋白级分

    公开(公告)号:US07887797B2

    公开(公告)日:2011-02-15

    申请号:US11666690

    申请日:2005-10-27

    IPC分类号: A61K39/00

    CPC分类号: C07K16/065 C07K2317/21

    摘要: The present invention relates to novel pharmaceutical compositions comprising fractions of human immunoglobulin preparations, novel applications of these compositions and a method for manufacturing the compositions.

    摘要翻译: 本发明涉及包含人免疫球蛋白制剂级分的新型药物组合物,这些组合物的新应用和制备该组合物的方法。